Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06577675 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Progression of a Group of Patients Suffering From Emotional Dysregulation But Heterogeneous in Terms of Diagnosis, Benefiting From the DBT Group Programme.

Study acronym: PEAC-TRE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 11 months later Sep 2025 → Sep 2027
See other at-risk trials from Centre Hospitalier Universitaire de Saint Etienne

Record History

  1. Primary completion pushed from Sep 2025 to Sep 2027 Completion pushed from May 2026 to May 2028 · Eligibility criteria expanded, about 10 words · Secondary endpoints: details revised at 1 of 1 entry · 1 more Show 4 more changesShow less
    • Completion pushed from May 2026 to May 2028
    • Eligibility criteria expanded, about 10 words
    • Secondary endpoints: details revised at 1 of 1 entry
    • Collaborators: details revised at 1 of 1 entry
  2. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Apr 2025 to Apr 17, 2025 · Site details revisedv8 Show 2 more changesShow less
    • Start date changed from estimate of Apr 2025 to Apr 17, 2025
    • Site details revised
  3. Start date: Mar 2025 to Apr 2025v7
  4. Start date: Feb 2025 to Mar 2025v6
  5. Re-verified, no change to tracked fieldsv5
Show 3 earlier versionsHide 3 earlier versions
  1. Start date: Dec 2024 to Feb 2025 Primary completion date: Apr 2025 to Sep 2025 · Completion date: Dec 2025 to May 2026v4 Show 2 more changesShow less
    • Primary completion date: Apr 2025 to Sep 2025
    • Completion date: Dec 2025 to May 2026
  2. Start date: Sep 2024 to Dec 2024 Site contact updatedv3 Show 1 more changeShow less
    • Site contact updated
  3. Site contact updatedv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Human beings experience emotions and have the ability to manage them, but when these abilities are undermined by mental illness, the result is emotional dysregulation. Borderline patients (1 to 4% of the population) suffer from this symptom and can benefit from a specific therapy: DBT (Dialectical Behaviour Therapy; Linehan, 1993). Created specifically for this condition, DBT significantly reduces emotional dysregulation, a dimension at the root of behavioural disorders that is known to be poorly relieved by drug treatments. The DBT group training programme offers patients the opportunity to learn and practise emotional regulation skills. Four types of skills are taught skills: mindfulness, interpersonal skills, emotional regulation and and distress tolerance. This therapy is part of the psychiatric care, in which patients take responsibility in their own care. There are many studies showing the effectiveness of DBT and its programme with borderline patients. But there are other pathologies concerned by emotional dysregulation: thymic disorders in particular bipolar (1 to 2.5%), addictive disorders (8 to 10%), eating disorders (ADD, 10%), post-traumatic stress disorder (PTSD, 2%).
Trial Details
NCT Number NCT06577675
Lead Sponsor Centre Hospitalier Universitaire de Saint Etienne
Collaborators: Groupement Interrégional de Recherche Clinique et d'Innovation
Conditions Emotion Regulation, Emotional Disorder
Enrollment 32 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov